TScan Therapeutics Appoints Commercial Leader Stephen Camiolo as Senior Vice President, Market Access
We are delighted to welcome Stephen to TScan at this stage of growth for the Company,” said Gavin MacBeath, Ph.D., Chief Executive Officer. “His robust commercial leadership experience includes over ...
Ascentage Pharma Reports Full Year 2024 Unaudited Financial Results and Business Updates
Revenue in 2024 increased 342%year-over-year to US$134.3 million (RMB980.7 million), attributable in part to Takeda’s option payment and strong ...